Business · 19/08/2015Updated: 10/17/2026 · 1 min read
FDA's CDRH to Participate in IMDRF's Regulated Product Submission Table of Contents Pilot Program
Summary
The FDA's CDRH is joining the IMDRF's pilot program to evaluate the Table of Contents structure and gather input from industry participants, with the goal of improving the premarket approval process for medical devices.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →